WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
SanDisk (SNDK.US): Price increase, and full payment is required!
New stock news | Farasis Energy submits application to Hong Kong Stock Exchange, focusing on integrated energy storage system solutions, with five major customers contributing 80% of revenue.
Hua Jin Securities: How will industries rotate during the main rise of the spring market?
SanDisk (SNDK.US): Price increase, and full payment is required!
New stock news | Farasis Energy submits application to Hong Kong Stock Exchange, focusing on integrated energy storage system solutions, with five major customers contributing 80% of revenue.
Hua Jin Securities: How will industries rotate during the main rise of the spring market?
RECOMMEND
Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026
Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026
“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026
